RLMD·75955J402·US·equity·Healthcare - Biotechnology-13D/G
RLMD (RELMADA THERAPEUTICS INC) is held by 48 institutional investors as of Q1 2026. Largest holders: JANUS HENDERSON GROUP PLC ($76.9M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($33.2M), MARSHALL WACE, LLP ($31.2M). Net institutional sentiment: Mixed.
See how RLMD's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer